Wielojęzyczna baza danych jest na wczesnym etapie beta - zgłoś wszelkie zauważone problemy.
Źródło danych:
2022.
Strona zaktualizowana:
2025-05-28
Terapia zastępcza nikotynowa (NRT) jest dozwolona w Botswanie. Oznacza to, że stosowanie i sprzedaż produktów NRT są legalne, jednak ich zakup wymaga recepty. Produkty NRT są dostępne w aptekach na terenie kraju, jednak nie istnieje żadne wsparcie ze strony instytucji rządowych w zakresie pokrycia kosztów tych produktów.
Regulacje
Dozwolone
1
2022
Źródła:
- WHO report on the global tobacco epidemic, 2023. Available at: https://cdn.who.int/media/docs/default-source/country-profiles/tobacco/gtcr-2023/tobacco-2023-bwa.pdf?sfvrsn=4f687158_3&download=true. Accessed: 6 May 2025.
Dostępność
Tak
1
2022
| Year | Value | Reference/Comment |
|---|---|---|
| 2019 | Nie | 1A |
| 2022 | Nie | 1B A |
Źródła:
- WHO Report on the Global Tobacco Epidemic 2019. https://www.who.int/tobacco/global_report/en/ (2019).
- WHO report on the global tobacco epidemic, 2023. Available at: https://cdn.who.int/media/docs/default-source/country-profiles/tobacco/gtcr-2023/tobacco-2023-bwa.pdf?sfvrsn=4f687158_3&download=true. Accessed: 6 May 2025.
Komentarze:
- A prescription is required.
Tak
2
2019
Apteka
2
2019
Źródła:
- WHO report on the global tobacco epidemic, 2023. Available at: https://cdn.who.int/media/docs/default-source/country-profiles/tobacco/gtcr-2023/tobacco-2023-bwa.pdf?sfvrsn=4f687158_3&download=true. Accessed: 6 May 2025.
- WHO Report on the Global Tobacco Epidemic 2019. https://www.who.int/tobacco/global_report/en/ (2019).
Komentarze:
- A prescription is required.
Formalne wsparcie
Nie
1
A
2022
Źródła:
- WHO report on the global tobacco epidemic, 2023. Available at: https://cdn.who.int/media/docs/default-source/country-profiles/tobacco/gtcr-2023/tobacco-2023-bwa.pdf?sfvrsn=4f687158_3&download=true. Accessed: 6 May 2025.
Komentarze:
- NRT cost is not covered by the government.
Publications
Tobacco harm reduction in Sub-Saharan Africa
With the number of tobacco users across the continent set to rise by 2025, we look at the current state of tobacco harm reduction in the region, assessing the progress made so far and the obstacles preventing greater adoption of safer nicotine products.
The GSTHR database is updated regularly by our team.
However, please be aware that the information we provide does not constitute legal advice.
We cannot guarantee that the information is up to date or accurate, as the regulatory status of different product
categories can change at short notice and with little publicity.
If you wish to check the legal status of use or possession of any safer nicotine product in a specific country or region,
you should verify the information independently.
If you have reason to think that the information supplied on the GSTHR is inaccurate, please contact us with details
and any references and we will rectify any errors.